Vera Therapeutics Launches with $80 Million Series C Financing to Develop Phase 2b Novel Biologic for Kidney Disease
Amount Raised
$80 Million
Round Type
Series C
BrisbaneBiotechnologyHealth CareTherapeuticsDescription
Vera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases, today announced its launch backed by $80 million Series C financing led by Abingworth LLP. Other investors included Sofinnova Investments, Longitude Capital, Fidelity Management & Research Company LLC, Surveyor Capital (a Citadel company), Octagon Capital, Kleiner Perkins, GV (formerly Google Ventures), and Alexandria Venture Investments.
Quick answer
Vera Therapeutics, Inc. raised $80 Million in a Series C round, dated January 19, 2021. Vera Therapeutics, Inc. is based in Brisbane, California, United States.
- How much did Vera Therapeutics, Inc. raise?
- Vera Therapeutics, Inc. raised $80 Million in a Series C round on January 19, 2021.
- What does Vera Therapeutics, Inc. do?
- Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for serious immunological diseases to improve patients’ lives.
- Where is Vera Therapeutics, Inc. based and how big is it?
- Vera Therapeutics, Inc. is based in Brisbane, California, United States. Fundz records about 160 employees.
- Who are the decision-makers at Vera Therapeutics, Inc?
- Fundz holds 2 contacts at Vera Therapeutics, Inc., including the Chief People Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Vera Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Tenaya Therapeutics raised $106M (Series C) on March 1, 2021.
- Artiva Biotherapeutics raised $120M (Series B) on February 26, 2021.
- Silence Therapeutics plc raised $45M on February 18, 2021.
- Phio Pharmaceuticals raised $14M on February 16, 2021.
- Oragenics raised $21M (Series C) on February 12, 2021.
- Acrivon Therapeutics raised $16M on February 12, 2021.
Who to call at Vera Therapeutics, Inc., and when
A new round usually means Vera Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vera Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vera Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vera Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vera Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Vera Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.